| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29033-214-01 | 29033-214 | HUMAN PRESCRIPTION DRUG | Carisoprodol | Carisoprodol | TABLET | ORAL | 20211001 | N/A | ANDA | ANDA207237 | Nostrum Laboratories, Inc. | CARISOPRODOL | 350 mg/1 | 100 TABLET in 1 BOTTLE (29033-214-01) |
| 29033-207-01 | 29033-207 | HUMAN PRESCRIPTION DRUG | Carisoprodol | Carisoprodol | TABLET | ORAL | 20170512 | N/A | ANDA | ANDA207237 | Nostrum Laboratories, Inc. | CARISOPRODOL | 250 mg/1 | 100 TABLET in 1 BOTTLE (29033-207-01) |
| 71335-2708-1 | 71335-2708 | HUMAN PRESCRIPTION DRUG | Carisoprodol | Carisoprodol | TABLET | ORAL | 20250728 | N/A | ANDA | ANDA207237 | Bryant Ranch Prepack | CARISOPRODOL | 250 mg/1 | 100 TABLET in 1 BOTTLE (71335-2708-1) |
| 63629-9144-1 | 63629-9144 | HUMAN PRESCRIPTION DRUG | Carisoprodol | Carisoprodol | TABLET | ORAL | 20220126 | N/A | ANDA | ANDA207237 | Bryant Ranch Prepack | CARISOPRODOL | 250 mg/1 | 100 TABLET in 1 BOTTLE (63629-9144-1) |